Schedule 13G ownership disclosure

ONCOCYTE CORPORATION

Security class unavailable · CUSIP: 68235C107

Event date: 2023-04-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,641,824
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001590144-23-000024
Form type
SC 13G/A
Filer
Insight Molecular Diagnostics Inc.
CIK
CIK 1642380
Filed
Apr 14, 2023
Reporting period
Apr 14, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub